Schedule 13D ownership disclosure

OPIANT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 683750103

Event date: 2013-08-01

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
952,820
Percent of class
27.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001385508-18-000015
Form type
SC 13D
Filer
OPIANT PHARMACEUTICALS, INC.
CIK
CIK 1385508
Filed
Feb 28, 2018
Reporting period
Aug 01, 2013
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub